Cochlear expands treatment options for individuals with single-sided deafness
By Ryan Lopez, Director, Nucleus Product Management & Marketing In January 2022, Cochlear received FDA approval to treat patients with single-sided deafness (SSD) with the Cochlear™ Nucleus® System. This approval […]